0000902664-24-004393.txt : 20240618
0000902664-24-004393.hdr.sgml : 20240618
20240618161106
ACCESSION NUMBER: 0000902664-24-004393
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 241051868
BUSINESS ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 124 DVORA HANEVI'A ST.
CITY: TEL AVIV
STATE: L3
ZIP: 6944020
BUSINESS PHONE: 972 (3) 914-8213
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 124 DVORA HANEVI'A ST.
CITY: TEL AVIV
STATE: L3
ZIP: 6944020
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRIDGER MANAGEMENT, LLC
CENTRAL INDEX KEY: 0001166309
ORGANIZATION NAME:
IRS NUMBER: 582553507
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 90 PARK AVENUE, 40TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-918-0820
MAIL ADDRESS:
STREET 1: 90 PARK AVENUE, 40TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: BRIDGER MANAGEMENT LLC
DATE OF NAME CHANGE: 20020130
144
1
primary_doc.xml
144
0001166309
XXXXXXXX
LIVE
0000818686
Teva Pharmaceutical Industries Limited
001-16174
124 Dvora HaNevi'a St
Tel Aviv
L3
6944020
972-3-914-8213
Bridger Management, LLC (1)
Shareholder
Ordinary Shares
Piper Sandler & Co.
1 Greenwich Plaza
Greenwich
CT
06830
519000
8885280.00
1132640597
06/18/2024
NYSE
Ordinary Shares
06/20/2017
See Remark 2
See Remark 2
N
519000
06/20/2017
See Remark 2
Y
(1) Bridger Management, LLC ("Bridger") serves as the investment manager of Swiftcurrent Master Fund, Ltd. which holds the shares covered by this Form 144. Roberto Mignone, Founder and Managing Partner of Bridger, is a member of the board of directors of the Issuer. (2) The shares reported herein to be sold were originally acquired through open market purchases on dates ranging from June 20, 2017 to May 10, 2018.
06/18/2024
Bridger Management, LLC, By: /s/ Matthew P. Truax, General Counsel and Chief Compliance Officer